Literature DB >> 3731892

Effectiveness of a new oxygen demand valve in chronic hypoxemia.

M E Rinow, A R Saltzman.   

Abstract

The purpose of this study was to compare the efficacy of nasal oxygen delivery by an inspiratory demand valve, which delivers oxygen only during the inspiratory phase, to standard continuous flow oxygen. The inspiratory demand valve attaches to an oxygen source and delivers oxygen after the sensor detects negative pressure through a standard nasal cannula. Seventeen male patients with chronic hypoxemia secondary to COPD were studied under resting conditions. Nine patients with hypoxemia at rest or with exercise were studied using an exercise protocol. Oxygen was delivered at a flow rate which improved the oxygen saturation by 4 percent. Oxygen saturation was measured continuously by an ear oximeter. The results indicate that oxygen saturation was not significantly different for either method of oxygen delivery at rest or during exercise. The time oxygen was delivered was significantly reduced during demand valve use, being 55 percent less at rest and 52 percent less during exercise when compared to continuous oxygen. Further study would be helpful to determine whether the device would reliably deliver oxygen during continuous use and whether it could be adapted to portable systems.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3731892     DOI: 10.1378/chest.90.2.204

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  2 in total

1.  Critical comparisons of the clinical performance of oxygen-conserving devices.

Authors:  Aishwarya Palwai; Mary Skowronski; Albert Coreno; Colin Drummond; E R McFadden
Journal:  Am J Respir Crit Care Med       Date:  2010-02-04       Impact factor: 21.405

2.  Evaluation and application of a method for estimating nasal end-tidal O2 fraction while administering supplemental O2.

Authors:  Kyle M Burk; Kai Kuck; Joseph A Orr
Journal:  J Clin Monit Comput       Date:  2019-02-06       Impact factor: 2.502

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.